Literature DB >> 16575406

Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo.

G M Wahl1.   

Abstract

P53 is a transcription factor that can cause cells to be eliminated by apoptosis or senescent-like arrest upon its activation by irreparable genetic damage, excessively expressed oncogenes, or a broad spectrum of other stresses. As P53 executes life and death decisions, its activity must be stringently regulated, which implies that it is not likely to be controlled by a simple regulatory mechanism involving a binary on-off switch. This brief review will summarize a subset of the new information presented at the 10th P53 workshop in Dunedin, New Zealand in November 2004 as well as very recent publications that provide new insights into the molecular regulators of P53. Data emerging from mouse models provide a fundamentally different view of how P53 is regulated than suggested by more traditional in vitro approaches. The differences between cell culture and mouse models demonstrate the importance of preserving stoichiometric relationships between P53 and its various regulators to obtain an accurate view of the relevant molecular mechanisms that control P53 activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575406     DOI: 10.1038/sj.cdd.4401911

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  11 in total

1.  Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2.

Authors:  Elin Hallan Naderi; Aart G Jochemsen; Heidi Kiil Blomhoff; Soheil Naderi
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

2.  Roles of HAUSP-mediated p53 regulation in central nervous system development.

Authors:  N Kon; J Zhong; Y Kobayashi; M Li; M Szabolcs; T Ludwig; P D Canoll; W Gu
Journal:  Cell Death Differ       Date:  2011-02-25       Impact factor: 15.828

3.  Mouse models for the p53 R72P polymorphism mimic human phenotypes.

Authors:  Feng Zhu; Martijn E T Dollé; Thomas R Berton; Raoul V Kuiper; Carrie Capps; Alexsandra Espejo; Mark J McArthur; Mark T Bedford; Harry van Steeg; Annemieke de Vries; David G Johnson
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

Review 4.  p53 regulation by ubiquitin.

Authors:  Christopher L Brooks; Wei Gu
Journal:  FEBS Lett       Date:  2011-05-27       Impact factor: 4.124

5.  HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.

Authors:  Anna Phillips; Amina Teunisse; Suzanne Lam; Kirsten Lodder; Matthew Darley; Muhammad Emaduddin; Anja Wolf; Julia Richter; Job de Lange; Matty Verlaan-de Vries; Kristiaan Lenos; Anja Böhnke; Frank Bartel; Jeremy P Blaydes; Aart G Jochemsen
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

6.  Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin.

Authors:  Jennifer L Illuzzi; Cassie A Vickers; Eric B Kmiec
Journal:  J Mol Neurosci       Date:  2011-04-05       Impact factor: 3.444

Review 7.  New insights into p53 activation.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Cell Res       Date:  2010-04-20       Impact factor: 25.617

Review 8.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

Review 9.  Modes of p53 regulation.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

10.  The C terminus of p53 binds the N-terminal domain of MDM2.

Authors:  Masha V Poyurovsky; Chen Katz; Oleg Laptenko; Rachel Beckerman; Maria Lokshin; Jinwoo Ahn; In-Ja L Byeon; Ronen Gabizon; Melissa Mattia; Andrew Zupnick; Lewis M Brown; Assaf Friedler; Carol Prives
Journal:  Nat Struct Mol Biol       Date:  2010-07-18       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.